McLean Asset Management Corp decreased its holdings in UnitedHealth Group Incorporated (NYSE:UNH – Get Rating) by 5.6% during the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 2,022 shares of the healthcare conglomerate’s stock after selling 120 shares during the quarter. McLean Asset Management Corp’s holdings in UnitedHealth Group were worth $956,000 at the end of the most recent reporting period.
A number of other institutional investors and hedge funds also recently made changes to their positions in UNH. UMB Bank n.a. lifted its holdings in UnitedHealth Group by 0.6% during the first quarter. UMB Bank n.a. now owns 148,842 shares of the healthcare conglomerate’s stock valued at $70,341,000 after purchasing an additional 838 shares in the last quarter. CHICAGO TRUST Co NA lifted its holdings in shares of UnitedHealth Group by 1.5% in the first quarter. CHICAGO TRUST Co NA now owns 13,512 shares of the healthcare conglomerate’s stock worth $6,386,000 after buying an additional 198 shares in the last quarter. Acropolis Investment Management LLC lifted its holdings in shares of UnitedHealth Group by 10.3% in the first quarter. Acropolis Investment Management LLC now owns 11,968 shares of the healthcare conglomerate’s stock worth $5,656,000 after buying an additional 1,121 shares in the last quarter. RMR Wealth Builders lifted its holdings in shares of UnitedHealth Group by 74.8% in the first quarter. RMR Wealth Builders now owns 1,124 shares of the healthcare conglomerate’s stock worth $531,000 after buying an additional 481 shares in the last quarter. Finally, Kesler Norman & Wride LLC lifted its holdings in shares of UnitedHealth Group by 2.1% in the first quarter. Kesler Norman & Wride LLC now owns 17,298 shares of the healthcare conglomerate’s stock worth $8,175,000 after buying an additional 350 shares in the last quarter. Hedge funds and other institutional investors own 92.61% of the company’s stock.
UnitedHealth Group Price Performance
Shares of NYSE UNH opened at $476.76 on Thursday. The stock has a market capitalization of $443.88 billion, a price-to-earnings ratio of 21.80, a PEG ratio of 1.34 and a beta of 0.68. UnitedHealth Group Incorporated has a 12 month low of $445.68 and a 12 month high of $558.10. The firm’s 50 day simple moving average is $486.82 and its 200-day simple moving average is $493.14. The company has a debt-to-equity ratio of 0.71, a current ratio of 0.81 and a quick ratio of 0.81.
UnitedHealth Group Increases Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 27th. Shareholders of record on Monday, June 19th will be issued a $1.88 dividend. The ex-dividend date is Thursday, June 15th. This represents a $7.52 dividend on an annualized basis and a yield of 1.58%. This is a positive change from UnitedHealth Group’s previous quarterly dividend of $1.65. UnitedHealth Group’s dividend payout ratio (DPR) is presently 34.39%.
Analysts Set New Price Targets
Several equities research analysts recently weighed in on UNH shares. Cantor Fitzgerald started coverage on shares of UnitedHealth Group in a research report on Thursday, April 20th. They issued an “overweight” rating and a $591.00 price target on the stock. Piper Sandler started coverage on shares of UnitedHealth Group in a research report on Thursday, May 25th. They issued an “overweight” rating and a $580.00 price target on the stock. TD Cowen reduced their price target on shares of UnitedHealth Group from $596.00 to $562.00 and set an “outperform” rating on the stock in a research report on Monday, April 17th. Oppenheimer reiterated an “outperform” rating and set a $610.00 price objective on shares of UnitedHealth Group in a research report on Monday, April 17th. Finally, Truist Financial cut their price objective on shares of UnitedHealth Group from $610.00 to $580.00 in a research report on Wednesday, June 14th. One investment analyst has rated the stock with a hold rating, fourteen have given a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat, the company presently has an average rating of “Buy” and an average target price of $592.68.
Insider Buying and Selling at UnitedHealth Group
In other UnitedHealth Group news, CEO Andrew Witty sold 6,160 shares of the firm’s stock in a transaction on Thursday, April 27th. The stock was sold at an average price of $487.49, for a total value of $3,002,938.40. Following the transaction, the chief executive officer now owns 86,564 shares in the company, valued at approximately $42,199,084.36. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. In other news, EVP Erin Mcsweeney sold 1,008 shares of UnitedHealth Group stock in a transaction on Friday, April 21st. The stock was sold at an average price of $484.58, for a total transaction of $488,456.64. Following the transaction, the executive vice president now owns 10,359 shares in the company, valued at approximately $5,019,764.22. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, CEO Andrew Witty sold 6,160 shares of the firm’s stock in a transaction dated Thursday, April 27th. The stock was sold at an average price of $487.49, for a total value of $3,002,938.40. Following the sale, the chief executive officer now directly owns 86,564 shares of the company’s stock, valued at $42,199,084.36. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 8,852 shares of company stock worth $4,313,962. Corporate insiders own 0.35% of the company’s stock.
About UnitedHealth Group
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Read More
- Get a free research report on UnitedHealth Group from StockNews.com
- Smartsheet Investors’ Hasty Exit Can Be Your Gain
- Agilent Technologies Stock: Ready to Rise off the Floor
- Oilfield Services Growing Faster Than Wider Energy Sector
- La-Z-Boy Reclines To The Buy Zone As Industry Normalizes
- Five stocks we like better than UnitedHealth Group
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.
